Advances in Infectious Diseases

Vol.8 No.3(2018), Paper ID 86623, 12 pages

DOI:10.4236/aid.2018.83011

 

Low Prevalence of Carbapenem Resistance in Clinical Isolates of Extended Spectrum Beta Lactamase (ESBL) Producing Escherichia coli in North Central, Nigeria

 

Kenneth I. Onyedibe, Emmanuel O. Shobowale, Mark O. Okolo, Michael O. Iroezindu, Tolulope O. Afolaranmi, Francisca O. Nwaokorie, Solomon O. Opajobi, Samson E. Isa, Daniel Z. Egah

 

Department of Medical Microbiology, University of Jos, Jos, Nigeria
Department of Medical Microbiology, Babcock University, Ilishan-Remo, Nigeria
Department of Medical Microbiology, University of Jos, Jos, Nigeria
Department of Medicine, University of Nigeria, Nsukka, Nigeria
Department of Epidemiology & Community Health, University of Jos, Jos, Nigeria
Division of Molecular Biology, Nigerian Institute of Medical Research, Lagos, Nigeria
Department of Medical Microbiology, University of Jos, Jos, Nigeria
Department of Medicine, University of Jos, Jos, Nigeria
Department of Medical Microbiology, University of Jos, Jos, Nigeria

 

Copyright © 2018 Kenneth I. Onyedibe, Emmanuel O. Shobowale, Mark O. Okolo, Michael O. Iroezindu, Tolulope O. Afolaranmi, Francisca O. Nwaokorie, Solomon O. Opajobi, Samson E. Isa, Daniel Z. Egah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Onyedibe, K. , Shobowale, E. , Okolo, M. , Iroezindu, M. , Afolaranmi, T. , Nwaokorie, F. , Opajobi, S. , Isa, S. and Egah, D. (2018) Low Prevalence of Carbapenem Resistance in Clinical Isolates of Extended Spectrum Beta Lactamase (ESBL) Producing Escherichia coli in North Central, Nigeria. Advances in Infectious Diseases, 8, 109-120. doi: 10.4236/aid.2018.83011.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.